British Journal of Urology · 1989 · 69 citations · 12 references
MedicinePharmacologyUrologyNeuroendocrinologyNeuropharmacologyPharmacodynamicsErectile DysfunctionReproductive PharmacologySexual DysfunctionVasoactive MedicationsErectile Function RestorationIntracavernosal Injection TherapyNeurogenic Erectile DysfunctionPenile Function AssessmentPenile HemodynamicsPenile PalpationUrinary Outflow ResistanceVasoactive Intestinal Peptide Signaling
Intracavernosally injected vasoactive intestinal polypeptide (VIP) (2 micrograms and 4 micrograms) resulted in penile tumescence even in men with predominantly organic impotence. Papaverine and phentolamine were successful in inducing erections in all subjects studied but the addition of VIP to this combination improved the erectile response further. A combination of papaverine and VIP produced penile rigidity similar to that with papaverine and phentolamine. While intracavernosal VIP alone produced disappointing penile responses, its combination with papaverine potentiated the response to this drug, probably by increasing venous outflow resistance.
12
Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile Failure
R Virag, Dafna Frydman, M. Legman et al. · Angiology · 1984 · 310 citations
Medicine, Pharmacology, Urology +14
J. M. Polak, Samir N. Mina, Jiang Gu et al. · The Lancet · 1981 · 155 citations
Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter.
Bent Ottesen, Gorm Wagner, R Virag et al. · BMJ · 1984 · 139 citations · Full text